After a politically charged back-and-forth, the US Food and Drug Administration sent a letter to the Senate stating that a decision on whether to allow the morning-after pill to be sold over the counter will be reached by the first of September.
WebProWorld
After a politically charged back-and-forth, the US Food and Drug Administration sent a letter to the Senate stating that a decision on whether to allow the morning-after pill to be sold over the counter will be reached by the first of September.